Drug Research

Santen, Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd., the specialty ophthalmology company headquartered in Osaka, Japan, and twoXAR, Inc., an artificial…
Read More...

Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization (CRO), today announced that it has entered into a collaboration with Frenova Renal…
Read More...

Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today…
Read More...

AMRI announced that it has entered into an agreement with the pharmaceutical group Ferrer  and Accord Healthcare, Inc. ("Accord Healthcare") to jointly develop and manufacture an…
Read More...

Valeant Pharmaceuticals International, Inc. and EyeGate Pharmaceuticals, Inc., a specialty pharmaceutical company that focuses on developing and commercializing products for treating…
Read More...

Otsuka Pharmaceutical Co., Ltd. and Lundbeck Canada announce that Health Canada issued a Notice of Compliance for REXULTI (brexpiprazole) for the treatment of schizophrenia in adults.…
Read More...

Imprimis Pharmaceuticals, Inc.an ophthalmology-focused pharmaceutical company announced that it has begun shipping its core sterile ophthalmic medications to select customers from its…
Read More...

Mayne Pharma Group Limited announced the launch of butalbital acetaminophen (APAP) tablets 50 mg/300 mg in the United States. Butalbital / APAP is indicated for the treatment of tension…
Read More...

X-Chem, Inc. announced that it has expanded its collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover new drug…
Read More...

AMRI, a global contract research and manufacturing organization working to improve patient outcomes and quality of life, has entered an alliance with Bruker Daltonics and HighRes…
Read More...

Portola Pharmaceuticals, Inc.® (PTLA) announced that it has signed a $150 million royalty agreement with HealthCare Royalty Partners (HCR). Under the terms of the agreement, Portola…
Read More...

Teva Pharmaceutical Industries Ltd., announced that it has filed an abbreviated new drug application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market…
Read More...

Lysogene announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to LYS-GM101, the company’s gene therapy drug candidate for treatment of GM1…
Read More...

Cocoon Biotech, Inc., is a biotechnology company focused on utilizing its silk protein-based drug delivery technology for the development of formulations to treat osteoarthritis and…
Read More...

HOPE BIOSCIENCES, INC. announced that it has acquired exclusive and worldwide rights to develop and commercialize HOPE 777, a unique MERTK/AXL/pan-c-MET tyrosine kinase inhibitor…
Read More...

GenSight Biologics, a biopharma company that discovers and develops innovative gene therapies for neurodegenerative retinal diseases and diseases of the central nervous system,…
Read More...

Ipsen announces that it has signed an agreement to take an equity stake in Akkadeas Pharma with an option to take control of the company in the future. Akkadeas Pharma is a…
Read More...

Noxopharm announces that it has entered into a research agreement with the University of Hong Kong to conduct research into the use of the drug idronoxil (NOX66 active ingredient) to…
Read More...

Medical researchers and IBM are asking for the public's help in identifying prospective treatments for childhood cancers. Scientists are searching for chemical drug candidates that…
Read More...

Endo International plc announced that one of its operating companies, Par Pharmaceutical has received final approval from the U.S. Food and Drug Administration for its New Drug…
Read More...